Biovica International AB (publ) (BIOVIC-B) - Cash Flow Conversion Efficiency

Latest as of July 2025: -0.670x

Based on the latest financial reports, Biovica International AB (publ) (BIOVIC-B) has a cash flow conversion efficiency ratio of -0.670x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-17.20 Million ≈ $-1.85 Million USD) by net assets (Skr25.68 Million ≈ $2.76 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See BIOVIC-B days of operational coverage to measure how many days the company can operate on defensive assets alone.

Biovica International AB (publ) - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Biovica International AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Biovica International AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Biovica International AB (publ) ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Medicon Hellas S.A. AT:MEDIC	0.008x
Co-Diagnostics, Inc. Common Stock NASDAQ:CODX	-0.489x
NFL Biosciences SAS PA:ALNFL	0.032x
Buxton Resources Ltd AU:BUX	-0.863x
Edinburgh Investment Trust LSE:EDIN	0.007x
Cannabist Company Holdings Inc NEO:CBST	0.161x
HEBEI CONSTR.GRP CORP YC1 F:H9D	N/A
Sri Adhikari Brothers Television Network Limited NSE:SABTNL	-36.713x

Annual Cash Flow Conversion Efficiency for Biovica International AB (publ) (2015–2025)

The table below shows the annual cash flow conversion efficiency of Biovica International AB (publ) from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see BIOVIC-B company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-04-30	Skr43.21 Million ≈ $4.65 Million	Skr-85.37 Million ≈ $-9.19 Million	-1.976x	-66.65%
2024-04-30	Skr96.64 Million ≈ $10.40 Million	Skr-114.58 Million ≈ $-12.33 Million	-1.186x	-73.67%
2023-04-30	Skr138.64 Million ≈ $14.92 Million	Skr-94.64 Million ≈ $-10.18 Million	-0.683x	-62.51%
2022-04-30	Skr124.09 Million ≈ $13.35 Million	Skr-52.13 Million ≈ $-5.61 Million	-0.420x	-123.00%
2021-04-30	Skr182.66 Million ≈ $19.66 Million	Skr-34.41 Million ≈ $-3.70 Million	-0.188x	+40.54%
2020-04-30	Skr78.22 Million ≈ $8.42 Million	Skr-24.78 Million ≈ $-2.67 Million	-0.317x	+8.13%
2019-04-30	Skr52.10 Million ≈ $5.61 Million	Skr-17.97 Million ≈ $-1.93 Million	-0.345x	-70.81%
2018-04-30	Skr73.71 Million ≈ $7.93 Million	Skr-14.88 Million ≈ $-1.60 Million	-0.202x	-66.66%
2017-04-30	Skr91.55 Million ≈ $9.85 Million	Skr-11.09 Million ≈ $-1.19 Million	-0.121x	+67.11%
2016-04-30	Skr25.48 Million ≈ $2.74 Million	Skr-9.38 Million ≈ $-1.01 Million	-0.368x	-432.23%
2015-04-30	Skr8.32 Million ≈ $894.93K	Skr922.00K ≈ $99.22K	0.111x	--

About Biovica International AB (publ)

ST:BIOVIC-B Sweden Biotechnology

Market Cap

$12.41 Million

Skr115.35 Million SEK

Market Cap Rank

#26502 Global

#572 in Sweden

Share Price

Skr0.42

Change (1 day)

+14.79%

52-Week Range

Skr0.28 - Skr0.84

All Time High

Skr66.10